Contents

Current Cancer Drug Targets, Volume 17 - Number 2

Meet Our Editorial Board Member

, 17(2): 99

William Cho


DOI: 10.2174/156800961702170109213433




Review Article

Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review

, 17(2): 100 - 108

Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang and Zhen-Zhou Jiang


DOI: 10.2174/1568009616666160112105824





Review Article

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors

, 17(2): 109 - 121

Alessandro Federico, Silvia Zappavigna, Marcello Dallio, Gabriella Misso, Francesco Merlino, Carmela Loguercio, Ettore Novellino, Paolo Grieco and Michele Caraglia


DOI: 10.2174/1568009616666160621101248





Review Article

Current Development of ROS-Modulating Agents as Novel Antitumor Therapy

, 17(2): 122 - 136

Nan Wang, Yue Wu, Jinlei Bian, Xue Qian, Hongzhi Lin, Haopeng Sun, Qidong You and Xiaojin Zhang


DOI: 10.2174/1568009616666160216125833





Review Article

Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma

, 17(2): 137 - 157

Hazem I. Assi and Rita E. Assi


DOI: 10.2174/1568009616666160719120053





Review Article

Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies

, 17(2): 158 - 168

Mounia Guerram, Aida Mejda Hamdi, Lu-Yong Zhang and Zhenzhou Jiang


DOI: 10.2174/1568009616666160603123014





Research Article

Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

, 17(2): 169 - 176

Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler and Yiyu Zou


DOI: 10.2174/1568009616666160331124759




Research Article

Grid-independent Descriptors (GRIND) Analysis and SAR Guided Molecular Docking Studies to Probe Selectivity Profiles of Inhibitors of Multidrug Resistance Transporters ABCB1 and ABCG2

, 17(2): 177 - 190

Talha Shafi and Ishrat Jabeen


DOI: 10.2174/1568009616666160901094140





Research Article

CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma

, 17(2): 191 - 197

Xiaoqing Jia, Guangyu Liu, Jingyi Cheng, Zhenzhou Shen and Zhimin Shao


DOI: 10.2174/1568009616666160426125058





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science